Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

JSPRJSPR
18 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in JASPER THERAPEUTICS INC

CITADEL ADVISORS LLC previously held 0 shares of JSPR (JASPER THERAPEUTICS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$29.2M

Total Shares Change

-3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$1.79
0
2025-Q3
Increased
589,449
+43.6%
$1.4M0.0%$2.49
34
2025-Q2
Increased
410,444
+9.4%
$2.3M0.0%$5.49
29
2025-Q1
Decreased
375,170
-11.4%
$1.6M0.0%$4.46
0
2024-Q4
Increased
423,610
+199.2%
$9.1M0.0%$20.95
44
2024-Q3
New
141,564
-
$2.7M0.0%$18.83
36
2024-Q2
Exited
0
-100.0%
$00.0%$22.70
0
2024-Q1
Decreased
16,210
-91.5%
$475,9260.0%$29.36
0
2023-Q4
Increased
191,155
+144.1%
$150,8210.0%$7.89
25
2023-Q3
Decreased
78,326
-94.5%
$54,8280.0%$7.00
0
2023-Q2
Decreased
1.4M
-64.5%
$2M0.0%$13.50
0
2023-Q1
Increased
4M
+28.0%
$7.3M0.0%$18.80
34
2022-Q4
Increased
3.1M
+1.1%
$1.5M0.0%$4.83
26
2022-Q3
Increased
3.1M
+4.3%
$2.4M0.0%$8.30
27
2022-Q2
Decreased
3M
-0.7%
$5.7M0.0%$19.50
0
2022-Q1
Decreased
3M
-1.7%
$10.6M0.0%$33.50
0
2021-Q4
Increased
3M
+1.4%
$22.8M0.0%$84.00
29
2021-Q3
New
3M
-
$29.2M0.0%$92.20
40

Other major holders of JSPR: Carlyle Group Inc., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used